STAT

JUNE 26, 2024

Makers of RSV vaccines for older adults saw their plans to try to expand usage hit a significant hurdle on Wednesday, when an expert committee that advises the Centers for Disease Control and Prevention on vaccines recommended changes that will likely see fewer older adults qualify for insurance coverage for these products.

Vaccines 134

Vaccines Insurance Coverage Insurance Immunization 134

STAT

OCTOBER 2, 2023

LONDON — Two pioneers of mRNA research — the technology that helped the world tame the virus behind the Covid-19 pandemic — won the 2023 Nobel Prize in medicine or physiology on Monday. Read the rest…

Immunization 145

Immunization Vaccines 145

European Pharmaceutical Review

MARCH 26, 2024

Moderna’s next-generation COVID-19 vaccine mRNA-1283 demonstrated a higher immune response against SARS-CoV-2, interim results from the company’s Phase III trial show. These findings were based on data comparing the treatment to mRNA-1273.222 (Spikevax ® ), Moderna’s licensed vaccine for the condition.

Vaccines 110

Vaccines Immunization 110

STAT

OCTOBER 2, 2023

and Europe are ramping up their campaigns urging eligible people to get another vaccine round against Covid and flu, promoting the immunizations as people’s best way to protect themselves and reduce pressure on health systems during what is expected to be another tough winter. LONDON — Health officials in the U.K.

Vaccines 128

Vaccines Immunization 128

Fierce Healthcare

SEPTEMBER 28, 2023

Sponsored by AstraZeneca Authored by Iskra Reic, Executive Vice President, Vaccines and Immune Therapies, AstraZeneca | While the majority of us benefit from the protection of vaccinations, some of the most vulnerable such as the immunocompromised need more options. October 2023 Z4-58637)

Immunization 98

Immunization Vaccines 98

The Checkup by Singlecare

SEPTEMBER 22, 2023

This year, there are new vaccines to help at-risk populations ward off severe sickness, including that caused by RSV. Here’s what you need to know about the new FDA-approved RSV vaccine. But young children, older adults, and individuals with weakened immune systems are at high risk of severe, potentially life-threatening RSV illness.

Vaccines 105

Vaccines Immunization Insurance FDA 105

European Pharmaceutical Review

JUNE 27, 2023

AC Immune SA has received Fast Track designation from the US Food and Drug Administration (FDA) for its anti-amyloid beta (Abeta) active immunotherapy vaccine candidate for Alzheimer’s disease. The anti-Abeta therapy “specifically targets the most toxic forms of Abeta” according to Dr Andrea Pfeifer, CEO of AC Immune SA.

Vaccines 105

Vaccines Immunization FDA 105

European Pharmaceutical Review

OCTOBER 2, 2023

The Nobel Assembly has awarded Hungarian biochemist Katalin Karikó and US immunologist Drew Weissman the Nobel Prize in Physiology or Medicine 2023 for their breakthrough findings in RNA vaccine development. The discovery was critical for developing effective mRNA vaccines during the COVID-19 pandemic.

Vaccines 111

Vaccines Immunization 111

European Pharmaceutical Review

APRIL 25, 2023

The R21/Matrix-M malaria vaccine, developed by the University of Oxford , has been approved for use in Ghana (13 April 2023) and was authorised for use in Nigeria on 17 April. How does the R21/Matrix-M vaccine work? This technology has been used successfully in Novavax’s COVID-19 vaccine.

Vaccines 111

Vaccines Immunization FDA 111

European Pharmaceutical Review

DECEMBER 14, 2022

and Merck have announced that a Phase IIb trial ( NCT03897881 ) of a personalised mRNA cancer vaccine (mRNA-4157/V940), in combination with KEYTRUDA ® , Merck’s anti-PD-1 therapy, demonstrated the first randomised evidence that a personalised neoantigen approach may be beneficial in treating melanoma. Moderna, Inc.

Vaccines 116

Vaccines Immunization 116

Digital Pharmacist

AUGUST 21, 2023

As we gear up for the upcoming flu season of 2023-2024, it’s important to reflect on the lessons of the previous year , and understand how the coming year may look different. The most effective preventive measure against the flu is getting an annual flu vaccine. According to the CDC, in the 2023-2024 season, the U.S.

Vaccines 98

Vaccines Communication Immunization 98

European Pharmaceutical Review

NOVEMBER 1, 2023

In July 2022, the World Health Organization (WHO) released its inaugural report on the pipeline of vaccines currently in development to prevent infections caused by antimicrobial resistance (AMR) bacterial pathogens. WHO referred to 61 bacterial vaccine candidates in diverse stages of clinical development. 1 WHO’s analysis was stark.

Vaccines 115

Vaccines Immunization 115

Digital Pharmacist

JANUARY 16, 2023

Creating a 2023 health awareness calendar this year is a great way to market your pharmacy while promoting patient health. . World Immunization Week: April 24-30. National Immunization Awareness Month. National Influenza Vaccination Week: December 6-12. Promoting Your 2023 Health Awareness Calendar.

Immunization 98

Immunization Vaccines Communication Hospitals 98

Pharmaceutical Technology

FEBRUARY 3, 2023

Only a few weeks into the new year, the prospect of getting a successful advanced HIV vaccine shrank after the discontinuation of yet another late-stage trial. On January 18, Janssen, a Johnson & Johnson (J&J) subsidiary, stated that its vaccine was not effective in preventing HIV infections.

Vaccines 117

Vaccines Immunization 117

Pharmaceutical Technology

APRIL 3, 2023

The World Health Organisation (WHO) has revised its recommendations regarding the use of Covid-19 vaccines following a meeting of the agency’s Strategic Advisory Group of Experts on Immunisation (SAGE). The panel emphasised that the extra booster dose recommendation only pertains to one shot and is not for continued annual booster vaccines.

Vaccines 111

Vaccines Immunization 111

The Checkup by Singlecare

SEPTEMBER 5, 2023

When you or your child get a vaccine, it’s natural to wonder about possible side effects. The meningitis vaccine is recommended for pre-teens , teens, and specific high-risk individuals with certain health conditions. As with most vaccines, mild side effects are common after the meningitis vaccine.

Vaccines 98

Vaccines Immunization Hospitals 98

European Pharmaceutical Review

DECEMBER 19, 2023

Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.

Vaccines 111

Vaccines Communication Immunization Documentation 111

Hospital Pharmacy Europe

JANUARY 25, 2023

The Joint Committee on Vaccination and Immunisation (JCVI) has advised offering Covid booster vaccinations in spring and autumn 2023 for patients deemed to be at high risk. The post Joint Committee on Vaccination and Immunisation provides advice on next round of Covid boosters appeared first on Hospital Pharmacy Europe.

Vaccines 98

Vaccines Immunization Hospitals 98

The Checkup by Singlecare

NOVEMBER 4, 2024

The chances of getting shingles increase with age as the immune system gets weaker. Shingrix is a very effective vaccine recommended for adults 50 and older and those with weakened immune systems. Starting in 2023, the Inflation Reduction Act of 2022 made vaccines more accessible for Medicare and Medicaid recipients.

Vaccines 52

Vaccines Immunization Insurance 52

European Pharmaceutical Review

FEBRUARY 14, 2023

Recently there have been several key advances in the clinical development of messenger RNA (mRNA) vaccines, including vaccines for RSV and a personalised cancer vaccine. Sarah Bundra, Pharmaceutical Analyst at GlobalData also warned about patient safety: “introducing mRNA carries the risk of activating the immune system.”

Vaccines 105

Vaccines Immunization FDA 105

European Pharmaceutical Review

OCTOBER 21, 2022

Clinical trial results presented at the US IDWeek conference, revealed a three-dose series of the HEPLISAV-B vaccine prevents hepatitis B virus (HBV) in HIV patients not previously vaccinated against or infected with the virus. At week 28, the study assessed the vaccine’s safety and levels of anti-HBV surface antibodies (HBsAbs).

Vaccines 96

Vaccines Immunization FDA 96

The Checkup by Singlecare

SEPTEMBER 10, 2024

Administered annually (ideally before the flu season, which peaks from December to February in the United States), flu vaccines work by preparing the immune system to recognize and combat the flu effectively. Most influenza vaccine reactions are mild and resolve quickly. Here’s what to know.

Vaccines 105

Vaccines Immunization Hospitals 105

Hospital Pharmacy Europe

DECEMBER 14, 2022

mRNA-4157/V940 which represents a personalised cancer vaccine has been found effective when combined with pembrolizumab in advanced melanoma. mRNA-4157/V940 is designed to stimulate an immune response by generating a specific T cell action based on the unique mutational signature of a patient’s tumour.

Vaccines 98

Vaccines Immunization Hospitals 98

pharmaphorum

MAY 10, 2021

BioNTech has said it plans to set up a regional base and new manufacturing site in Singapore so that the biotech can keep pace with demand for its mRNA-based coronavirus vaccine and pipeline products in other disease areas. It’s an important milestone for the company, which established a US headquarters in Cambridge, Massachusetts last year.

Vaccines 129

Vaccines Immunization 129

pharmaphorum

SEPTEMBER 3, 2021

Pfizer has vaulted ahead with its respiratory syncytial virus (RSV) vaccine, closing the gap with GlaxoSmithKline and Johnson & Johnson as the companies strive to bring the first licensed shot to market. At its recent business update, GSK said it was anticipating peak sales of more than $4 billion for its vaccine if approved.

Vaccines 88

Vaccines Immunization 88

European Pharmaceutical Review

SEPTEMBER 1, 2023

At the end of August 2023, BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP) had recommended its adapted Comirnaty mRNA-based vaccine for regulatory approval as preventive treatment against the COVID-19 Omicron XBB.1.5 Global RNA therapy clinical trials market to reach $3.5 subvariant.

Immunization 110

Immunization Vaccines 110

Digital Pharmacist

OCTOBER 5, 2022

The Medicare Open Enrollment period for 2023 is quickly approaching – this is a critical time for both your patients and your pharmacy. About Medicare Open Enrollment 2023. Part D plans will also cover most vaccines, except for those covered in Part B. Every year, the enrollment period runs from October 15 to December 7.

Independent Pharmacies 98

Independent Pharmacies Nursing Homes Insurance Hospitals 98

pharmaphorum

JANUARY 10, 2023

Since then, the two partners have developed multiple AI-based applications including a platform for selecting neoantigens for use in individualised cancer vaccines and an early warning system for high risk SARS-CoV-2 variants based on how well they can evade the immune system and their transmissibility.

Immunization 116

Immunization Vaccines 116

Digital Pharmacist

NOVEMBER 21, 2022

Food and Drug Administration (FDA) announced its approval of the Boostrix vaccine, commonly known as Tdap (combination of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis) for immunization administration during the third trimester of pregnancy to prevent pertussis in infants younger than two months of age.

Communication 98

Communication Documentation Immunization Vaccines 98

Hospital Pharmacy Europe

JULY 10, 2024

The UK is switching to a different pertussis vaccine for pregnant women following advice from the Joint Committee on Vaccination and Immunisation. Analysis showed antibody levels to polio type 2 were most affected by the maternal vaccination.

Vaccines 59

Vaccines Immunization Hospitals 59

Hospital Pharmacy Europe

OCTOBER 2, 2024

Pharmacist Dr João Gonçalves PhD considers the real-world evidence of a recent study demonstrating the feasibility and efficacy of a personalised peptide vaccine for glioblastoma – one of the most malignant primary brain tumours in adults. The median overall survival (OS) for the entire cohort was 31.9

Vaccines 52

Vaccines Immunization Chemotherapy Hospitals 52

Pharmafile

APRIL 18, 2023

CET/4:00 p.m. read more

Immunization 40

Immunization Vaccines 40

STAT

APRIL 5, 2024

An unprecedented crisis looms in India over supplies of injectable poliomyelitis vaccine, or IPV — a crucial tool in efforts to eradicate polio — now that Sanofi has shut its manufacturing plants in the country , The Economic Times reports. Sanofi is believed to cater to over 80% of India’s IPV dose requirements.

Vaccines 110

Vaccines Immunization 110

European Pharmaceutical Review

NOVEMBER 23, 2023

The pharmaceutical company will utilise T3 Pharmaceutical’s proprietary bacterial cancer therapy platform that consisting that delivers immune-modulating bioactive proteins to cancer cells and tumour micro-environments. Overall, the process enables the design of immuno-oncology combination therapies in one single agent.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Immunization Vaccines 115

Hospital Pharmacy Europe

JULY 10, 2024

The UK is switching to a different pertussis vaccine for pregnant women following advice from the Joint Committee on Vaccination and Immunisation. Analysis showed antibody levels to polio type 2 were most affected by the maternal vaccination.

Vaccines 52

Vaccines Immunization Hospitals 52

European Pharmaceutical Review

MAY 7, 2024

Injectable vaccines activate the immune system to help to prevent infectious conditions such as influenza. In 2023, North America accounted for the biggest market share due the region’s readiness to invest in innovative solutions such as injectable drug delivery systems.

Vaccines 94

Vaccines Compounding Immunization FDA 94

European Pharmaceutical Review

DECEMBER 12, 2023

He discusses why NK cell therapy’s ability to generate ‘synthetic immunity’ in the body means this modality holds potential as an anti-cancer treatment. We specialise in the development of new cutting-edge immunotherapies , based on the use of therapeutic antibodies capable of activating the immune system to fight cancer. percent.

Immunization 124

Immunization Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 124